Federated Models Offer New Paradigm for Data Monetization in Healthcare
A new report by datma explores how companies can use federated data models to scale RWD.
A CEO’s Guide to AI Exploration: Transforming Organizations and Mindsets
Try a variety of LLM-based tools yourself. Understand the risks, limitations, and who is working on putting quality frameworks and guardrails in place. Engage your employees and partners in discussions about what might now be possible.
presented by
The 5 Best Software to Buy for Managing a Spa Franchise
Choosing the right software translates directly into better client management, operational efficiency and growth for your spa franchise. Discover which tool is best for your business.
Ignoring RWD Endangers Drug Development
Enabling RWD-driven drug development accelerates the approval of more effective and affordable treatments. This approach successfully identifies patient patterns and density indicators and maps causal pathways.
Leading Clinical Trial Recruitment Strategies Center Around Real-World Data
By allowing study teams to design and conduct more inclusive and/or relevant studies, real-world data can enhance the standard of care and ultimately improve patient outcomes.
Liberating real-world data for use in clinical trials
Liberating the genetics, laboratory and pharmacy data that sits deep within healthcare subsystems, while protecting patient information and navigating the global regulatory landscape, is no easy task but would greatly help in the treatment of diseases.
Study finds real-world evidence replicates less than one-fifth of clinical trials
The researchers wrote that RWE could complement trials, but that observational methods are unlikely to take away the need for traditional clinical studies.
presented by
Why Your Patients Are Leaving and How to Stop It
Patient expectations continue to evolve, and healthcare practices that fail to adapt risk more than just revenue—they risk losing trust.
Parexel, Datavant partner on using real-world data in clinical trials
Parexel, one of the largest CROs in the world, said the partnership would involve connecting real-world data across the clinical trials it conducts.
Aetion exec sees real-world evidence, randomized trials playing complementary roles
Aetion President Jeremy Rassen said in an interview on the sidelines of the CB Insights Future of Health conference that rare diseases and Phase IV safety studies would be examples of situations better suited to real-world evidence.